Pharmacologic Therapies for Obesity: The Future is Here

<p>Pharmacologic Therapies for Obesity: The Future is Here</p> <p> </p> <p>Guest: Kyla M. Lara-Breitinger, M.D.</p> <p>Hosts: Sharonne N. Hayes, M.D.</p> <p>Join us in this expert podcast as we delve into the captivating world of GLP-1 receptor agonists (GLP-1RAs), exploring their profound impact on weight management and cardiometabolic effects.  We also discuss the potential cardiovascular benefits affecting patients with obesity and cardiovascular disease.</p> <p>Topics Discussed:</p> <ul><li> The popularity of the GLP-1RAs </li> <li> Short-term and long-term benefits and consequences </li> <li> Cardiovascular benefits with taking these medications </li> </ul> <p>Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at <a href='https://cveducation.mayo.edu'>https://cveducation.mayo.edu</a> or on Twitter <a href='https://www.twitter.com/mayocliniccv'>@MayoClinicCV</a> and <a href='https://twitter.com/MayoCVservices'>@MayoCVservices</a>.</p> <p>LinkedIn: <a href='https://www.linkedin.com/company/mayo-clinic-cardiovascular-services'>Mayo Clinic Cardiovascular Services</a></p> <p>Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in <a href='https://apps.apple.com/us/app/mayo-clinic-cardiovascular-cme/id1578924841'>Apple</a> or <a href='https://play.google.com/store/apps/details?id=org.mayoclinic.cvcme'>Google</a> stores today!</p> <p>No CME credit offered for this episode.</p> <p>Podcast episode transcript found <a href='https://mcdn.podbean.com/mf/web/ws7m7b/P-MayoCV115_Pharmacologic_Therapies_for_Obesity_Hayes_Lara_CC-Transcript-Final.pdf'>here</a>.</p> <p> </p> <p> </p>